ponatinib,blinatumomab
amgen,astellas,takeda,otsuka,incyte
['ponatinib', 'leusm', 'blinatumomab']
very promising survival with this chemotherapy and transplant sparing combination of blinatumomab and ponatinib in ph-positive all by at #ash22 #leusm 
Assistant Professor, 
Leukemia Department                                                                 
MD Anderson Cancer Center, Houston